Process for preparing tannate tablet, capsule or other solid...

Details Process for preparing tannate tablet, capsule or other solid... Process for preparing tannate tablet, capsule or other solid...

2007-09-25

2007-09-25

Tran, S. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S451000, C424S452000, C424S464000, C424S465000

Reexamination Certificate

active

10269027

ABSTRACT:
An active pharmaceutical ingredient is combined with tannic acid to form a tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or purification is then blended with pharmaceutically acceptable excipients to form a granulate which is processed into a tablet or capsule to generate a therapeutic solid dosage form.

REFERENCES:
patent: 2950309 (1960-08-01), Cavallito
patent: 3197370 (1965-07-01), Hanus et al.
patent: 3282789 (1966-11-01), Marty et al.
patent: 3591680 (1971-07-01), Greene et al.
patent: 4309989 (1982-01-01), Fahim
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4619934 (1986-10-01), Sunshine et al.
patent: 4749697 (1988-06-01), Sunshine et al.
patent: 4749711 (1988-06-01), Sunshine et al.
patent: 4749721 (1988-06-01), Sunshine et al.
patent: 4749722 (1988-06-01), Sunshine et al.
patent: 4749723 (1988-06-01), Sunshine et al.
patent: 4767402 (1988-08-01), Kost et al.
patent: 4839354 (1989-06-01), Sunshine et al.
patent: 5025019 (1991-06-01), Sunshine et al.
patent: 5164398 (1992-11-01), Sims et al.
patent: 5599846 (1997-02-01), Chopdekar et al.
patent: 5614178 (1997-03-01), Bloom et al.
patent: 5663415 (1997-09-01), Chopdekar et al.
patent: 5759579 (1998-06-01), Singh et al.
patent: 6037358 (2000-03-01), Gordziel
patent: 6063770 (2000-05-01), Falcon
patent: 6117452 (2000-09-01), Ahlgren et al.
patent: 6187315 (2001-02-01), Falcon
patent: 6287597 (2001-09-01), Gordziel
patent: 6306904 (2001-10-01), Gordziel
patent: 6869618 (2005-03-01), Kiel et al.
patent: 894609 (1962-04-01), None
Cypress Pharmaceutical, Inc., “R-Tannic-S A/D,” RX Only, Cypress Pharmaceutical, Inc. (Madison, MS), p. 1, 2, (Mar. 1, 2001).
DSC Laboratories, “Phenylephrine Tannate / Pyrilamine Tannate Suspension,” RX Only, DSC Laboratories (Muskegon, MI), p. 1, 2, (Aug. 1, 2001).
Ronald Goldberg, M.D., and Franklin Shuman, M.D., “Evaluation of a Prolonged Action Oral Antihistaminic Preparation as Treatment for Allergic Disorders,” Clinical Report, Clinical Medicine (Washington), vol. 72 (No. 9), p. 1475-1479, (Sep. 1, 1965).
John Weiler, M.D., et al, “Randomized, double-blind, parallel groups, placebo-controlled study of efficacy and safety of Rynatan in the Treatment of allergic rhinitis using an acute model ,” Annals of Allergy, ACAI (Iowa City, IA), vol. 64 (No. 1), p. 63-67, (Jan. 1, 1990).
Heybach J P et al, “Dietary Quinine Reduces Body Weight and Food Intake Independent of Aversive Taste”, Physiology & Behaviour, vol. 29, 1982, pp. 1171-1173, abstract only.

Affiliated with

Also associated with

Rating

Process for preparing tannate tablet, capsule or other solid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing tannate tablet, capsule or other solid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing tannate tablet, capsule or other solid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3746507